Piera Selvaggio, Esi Taci, Alessandra Barassi, Valentina Massa, Cristina Gervasini, Elena Lesma, Clara Bernardelli, Elisabetta Di Fede
{"title":"Exploring the uncharted role of cell senescence in rare diseases.","authors":"Piera Selvaggio, Esi Taci, Alessandra Barassi, Valentina Massa, Cristina Gervasini, Elena Lesma, Clara Bernardelli, Elisabetta Di Fede","doi":"10.1186/s13023-025-03778-1","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Cellular senescence is a biological process in which the cell cycle is arrested in response to DNA damage caused by different endogenous and exogenous stimuli. In senescent cells, activation of intracellular cascade induces epigenetic, morphological and metabolic changes. Among them, senescent status is characterized by an alteration of the epigenome and the establishment of a peculiar senescence-associated secretory phenotype (SASP), which contributes to the extracellular matrix remodeling and senescence spreading. Growing interest is directed towards senescence relevance both in physiological processes and in pathological ones, including rare progeroid syndromes. However, little is known about senescence contribution to the onset and development of rare diseases in which aging traits are not manifested.</p><p><strong>Main body: </strong>Here, we review the current knowledge about senescence involvement in four rare mendelian disorders of the epigenetic machinery (i.e. chromatinopathies) and four rare lung diseases, that can be considered a paradigm for understanding how epigenome alteration and aberrant microenvironment modification in senescence process might drive disease onset and progression. First, we report the main characteristics of chromatinopathies and the relation between the chromatin-related epigenetic defects and the senescence features in Sotos syndrome, Cornelia de Lange syndrome, Rett syndrome, and Kleefstra syndromes. Thereafter, we describe the pathological alteration and senescence involvement in cystic fibrosis, idiopathic pulmonary fibrosis, pulmonary arterial hypertension and lymphangioleiomyomatosis, considering them as models of rare lung diseases in which accumulation of senescent cells and their proinflammatory SASP have a central role.</p><p><strong>Conclusion: </strong>Exploring the role of senescence in different and less common diseases might promote the understanding of the senescent process as a novel player in rare disorders, for a more comprehensive vision of their complexity and the suggestion of novel possible therapeutical targets.</p>","PeriodicalId":19651,"journal":{"name":"Orphanet Journal of Rare Diseases","volume":"20 1","pages":"465"},"PeriodicalIF":3.5000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12403278/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Orphanet Journal of Rare Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13023-025-03778-1","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Cellular senescence is a biological process in which the cell cycle is arrested in response to DNA damage caused by different endogenous and exogenous stimuli. In senescent cells, activation of intracellular cascade induces epigenetic, morphological and metabolic changes. Among them, senescent status is characterized by an alteration of the epigenome and the establishment of a peculiar senescence-associated secretory phenotype (SASP), which contributes to the extracellular matrix remodeling and senescence spreading. Growing interest is directed towards senescence relevance both in physiological processes and in pathological ones, including rare progeroid syndromes. However, little is known about senescence contribution to the onset and development of rare diseases in which aging traits are not manifested.
Main body: Here, we review the current knowledge about senescence involvement in four rare mendelian disorders of the epigenetic machinery (i.e. chromatinopathies) and four rare lung diseases, that can be considered a paradigm for understanding how epigenome alteration and aberrant microenvironment modification in senescence process might drive disease onset and progression. First, we report the main characteristics of chromatinopathies and the relation between the chromatin-related epigenetic defects and the senescence features in Sotos syndrome, Cornelia de Lange syndrome, Rett syndrome, and Kleefstra syndromes. Thereafter, we describe the pathological alteration and senescence involvement in cystic fibrosis, idiopathic pulmonary fibrosis, pulmonary arterial hypertension and lymphangioleiomyomatosis, considering them as models of rare lung diseases in which accumulation of senescent cells and their proinflammatory SASP have a central role.
Conclusion: Exploring the role of senescence in different and less common diseases might promote the understanding of the senescent process as a novel player in rare disorders, for a more comprehensive vision of their complexity and the suggestion of novel possible therapeutical targets.
背景:细胞衰老是细胞周期因不同内源性和外源性刺激引起的DNA损伤而停止的生物学过程。在衰老细胞中,细胞内级联的激活引起表观遗传、形态和代谢的变化。其中,衰老状态的特征是表观基因组的改变和特殊的衰老相关分泌表型(SASP)的建立,这有助于细胞外基质的重塑和衰老的扩散。在生理过程和病理过程中,包括罕见的类早衰综合征,人们对衰老的相关性越来越感兴趣。然而,对于衰老对罕见疾病的发病和发展的贡献知之甚少,其中衰老特征没有表现出来。在这里,我们回顾了目前关于衰老参与四种罕见表观遗传机制孟德尔疾病(即色素病)和四种罕见肺部疾病的知识,这些知识可以被认为是理解衰老过程中表观基因组改变和异常微环境修饰如何驱动疾病发生和进展的范例。首先,我们报道了Sotos综合征、Cornelia de Lange综合征、Rett综合征和Kleefstra综合征中染色质病变的主要特征以及染色质相关表观遗传缺陷与衰老特征的关系。随后,我们描述了囊性纤维化、特发性肺纤维化、肺动脉高压和淋巴管平滑肌瘤病的病理改变和衰老参与,认为它们是罕见肺部疾病的模型,其中衰老细胞的积累及其促炎SASP具有核心作用。结论:探索衰老在不同和不常见疾病中的作用可能会促进对衰老过程作为罕见疾病的新参与者的理解,从而更全面地了解其复杂性并提出新的可能的治疗靶点。
期刊介绍:
Orphanet Journal of Rare Diseases is an open access, peer-reviewed journal that encompasses all aspects of rare diseases and orphan drugs. The journal publishes high-quality reviews on specific rare diseases. In addition, the journal may consider articles on clinical trial outcome reports, either positive or negative, and articles on public health issues in the field of rare diseases and orphan drugs. The journal does not accept case reports.